A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...

On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices ...

You might not think much about what makes a liver healthy or unhealthy. And when your liver starts to become unhealthy, you ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on ...

Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads ...